Jo‐Heon Kim

506 total citations
26 papers, 354 citations indexed

About

Jo‐Heon Kim is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Jo‐Heon Kim has authored 26 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Jo‐Heon Kim's work include Lung Cancer Treatments and Mutations (4 papers), Fibroblast Growth Factor Research (3 papers) and Metastasis and carcinoma case studies (3 papers). Jo‐Heon Kim is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Fibroblast Growth Factor Research (3 papers) and Metastasis and carcinoma case studies (3 papers). Jo‐Heon Kim collaborates with scholars based in South Korea and United States. Jo‐Heon Kim's co-authors include Yoo Duk Choi, Chan Choi, Ji Shin Lee, Jong Hee Nam, Jae Hyuk Lee, Jong‐Hee Nam, Chan Choi, Ji Shin Lee, Ga‐Eon Kim and Chang‐Soo Park and has published in prestigious journals such as Journal of Clinical Oncology, Gynecologic Oncology and Modern Pathology.

In The Last Decade

Jo‐Heon Kim

24 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jo‐Heon Kim South Korea 12 155 148 111 73 70 26 354
Tien Anh N. Tran United States 12 142 0.9× 124 0.8× 125 1.1× 53 0.7× 81 1.2× 32 392
Manoj Shah India 11 112 0.7× 121 0.8× 163 1.5× 79 1.1× 65 0.9× 29 346
Diana Lim Singapore 11 96 0.6× 77 0.5× 52 0.5× 58 0.8× 32 0.5× 30 415
Naikang Zhou China 10 250 1.6× 84 0.6× 141 1.3× 85 1.2× 49 0.7× 40 401
Diana Morlote United States 10 94 0.6× 160 1.1× 122 1.1× 42 0.6× 52 0.7× 25 390
Olga L. Bohn United States 11 81 0.5× 77 0.5× 141 1.3× 90 1.2× 54 0.8× 18 352
Joanna Huszno Poland 11 146 0.9× 131 0.9× 193 1.7× 61 0.8× 102 1.5× 37 425
Koji Minami Japan 10 75 0.5× 107 0.7× 128 1.2× 108 1.5× 69 1.0× 38 378
Alyssa Luvison United States 8 149 1.0× 104 0.7× 170 1.5× 211 2.9× 54 0.8× 9 430
Nicolas Weinbreck France 12 102 0.7× 56 0.4× 72 0.6× 35 0.5× 45 0.6× 21 280

Countries citing papers authored by Jo‐Heon Kim

Since Specialization
Citations

This map shows the geographic impact of Jo‐Heon Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo‐Heon Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo‐Heon Kim more than expected).

Fields of papers citing papers by Jo‐Heon Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo‐Heon Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo‐Heon Kim. The network helps show where Jo‐Heon Kim may publish in the future.

Co-authorship network of co-authors of Jo‐Heon Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Jo‐Heon Kim. A scholar is included among the top collaborators of Jo‐Heon Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo‐Heon Kim. Jo‐Heon Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Noh, Myung‐Giun, Jo‐Heon Kim, Eun Jeong Won, et al.. (2020). Frequency and Prognostic Value of IDH Mutations in Korean Patients With Cholangiocarcinoma. Frontiers in Oncology. 10. 1514–1514. 11 indexed citations
3.
Kim, Sung Sun, Yong Mee Cho, Hun‐Soo Kim, et al.. (2020). Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity—a comparative study with papillary renal cell carcinoma. Modern Pathology. 33(4). 690–699. 46 indexed citations
4.
Cho, Sang‐Hee, Jo‐Heon Kim, Chang‐Soo Hong, et al.. (2020). The role of fibroblast growth factor receptor 4 (FGFR4) signaling in anti-EGFR resistance in colon cancer.. Journal of Clinical Oncology. 38(15_suppl). 4060–4060.
5.
Kim, Haeryoung, Soyeon An, Kyoung Bun Lee, et al.. (2019). Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study. Cancer Research and Treatment. 52(1). 263–276. 15 indexed citations
6.
Kim, Jo‐Heon, Woo‐Youl Jang, Tae‐Young Jung, et al.. (2019). Recurrent Glioma With Lineage Conversion From Oligodendroglioma to Astrocytoma in Two Cases. Frontiers in Oncology. 9. 828–828. 5 indexed citations
7.
Shim, Hyun‐Jeong, Min‐Ho Shin, Hee Nam Kim, et al.. (2015). The Prognostic Significance of <i>FGFR4</i> Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy. Cancer Research and Treatment. 48(1). 71–79. 11 indexed citations
8.
Kim, Jo‐Heon, Hee-Kyung Kim, Kyung‐Sub Moon, et al.. (2015). VE1 immunohistochemical detection of the BRAF V600E mutation in thyroid carcinoma: a review of its usefulness and limitations. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 467(2). 155–168. 20 indexed citations
9.
Choi, Yoo Duk, Young Kim, Jo‐Heon Kim, et al.. (2013). Intravascular Papillary Endothelial Hyperplasia of the Chest Wall Misdiagnosed as a Malignancy on Fine Needle Aspiration. The Korean Journal of Pathology. 47(5). 499–499. 4 indexed citations
10.
Kim, Taeyun, Hyun Joo Song, Sun Young Shin, et al.. (2013). Clarithromycin-resistantHelicobacter pyloriAssociated with 23S rRNA Point Mutations in Jeju Island. Korean Journal of Gastroenterology. 61(5). 252–252. 9 indexed citations
11.
Seong, Gil Myeong, et al.. (2012). Clinicopathological review of immunohistochemically defined Kikuchi–Fujimoto disease—including some interesting cases. Clinical Rheumatology. 31(10). 1463–1469. 15 indexed citations
12.
13.
Kim, Ga‐Eon, Jo‐Heon Kim, Ji Shin Lee, et al.. (2011). Stromal Matrix Metalloproteinase-14 Expression Correlates With the Grade and Biological Behavior of Mammary Phyllodes Tumors. Applied immunohistochemistry & molecular morphology. 20(3). 298–303. 27 indexed citations
14.
Kim, Jo‐Heon, et al.. (2011). Calcifying Fibrous Pseudotumor of the Anterior Mediastinum. The Korean Journal of Thoracic and Cardiovascular Surgery. 44(4). 318–320. 7 indexed citations
15.
Kim, Jo‐Heon, et al.. (2011). Sinonasal teratocarcinosarcoma with rhabdoid features. Pathology International. 61(12). 762–767. 9 indexed citations
16.
Kim, Jo‐Heon, et al.. (2011). Mucin‐positive epithelial mesothelioma of the peritoneum: Small bowel involvement. Pathology International. 61(12). 756–761. 3 indexed citations
17.
Kim, Jo‐Heon, Yoo Duk Choi, Ji Shin Lee, et al.. (2010). Utility of Thyroid Transcription Factor-1 and CDX-2 in Determining the Primary Site of Metastatic Adenocarcinomas in Serous Effusions. Acta Cytologica. 54(3). 277–282. 8 indexed citations
18.
Kim, Jo‐Heon, Ga‐Eon Kim, Yoo Duk Choi, et al.. (2009). Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks. Diagnostic Cytopathology. 37(4). 258–261. 34 indexed citations
19.
Kim, Jo‐Heon, Yoo Duk Choi, Ji Shin Lee, et al.. (2009). Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens. Gynecologic Oncology. 116(1). 99–104. 51 indexed citations
20.
Choi, Yoo Duk, Jo‐Heon Kim, In‐Jae Oh, et al.. (2008). Effectiveness of sputum cytology using ThinPrep® method for evaluation of lung cancer. Diagnostic Cytopathology. 36(3). 167–171. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tien Anh N. Tran Breakdown of academic impact, for papers by Manoj Shah Breakdown of academic impact, for papers by Diana Lim Breakdown of academic impact, for papers by Naikang Zhou Breakdown of academic impact, for papers by Diana Morlote Breakdown of academic impact, for papers by Olga L. Bohn Breakdown of academic impact, for papers by Joanna Huszno Breakdown of academic impact, for papers by Koji Minami Breakdown of academic impact, for papers by Alyssa Luvison Breakdown of academic impact, for papers by Nicolas Weinbreck
Rankless by CCL
2026